Patent · US Expired

Compositions, methods and kits relating to thrombin degradation resistant fibroblast growth factor-1

US6982170B1 · kind B1 · utility

25Cited by
6References
18Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 17, 2001
Grant dateJan 3, 2006
Priority date
Expiry dateDec 17, 2021

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/501
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to novel degradation resistant FGF-1, and methods for producing and using the same. More specifically, the invention relates to identification of a thrombin degradation resistant FGF-1, an a nucleic acid encoding the same. The thrombin degradation resistant FGF-1 can elicit responses that are otherwise typically impeded by degradation of FGF-1 by thrombin. Thrombin degradation resistant FGF-1 is an important molecule for effecting an FGF-1 response that would be otherwise inhibited by thrombin. Thus, the present invention provides a powerful therapeutic for diseases or disorders wherein an FGF-1 response can mediate a reduction in the frequency or intensity of a symptom of the disease or disorder but for degradation of FGF-1 before it can effect the response.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.